Nauru vs Qatar: The number of people with susceptibility test result for rifampicin
Nauru
100
in 2021
Qatar
100
in 2021
Nauru rank
2nd
Qatar rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Nauru
- Qatar
How they compare
Nauru currently reports 100 against 100 in Qatar, a difference of 0.
Across all 5 years both countries report, Qatar has been ahead every year.
Nauru ranks 2nd and Qatar ranks 2nd of 146 countries.
Qatar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nauru | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 83.79 | 83.79 | Qatar |
| 2020s | 50 | 100 | 50 | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nauru or Qatar?
- Nauru, at 100 against 100 in Qatar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nauru and Qatar?
- 0, with Nauru ahead.
- How many years of comparable data are there for Nauru and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do Nauru and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- Nauru ranks 2nd and Qatar ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.